Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LabCorp announced its Covance Drug Development business has formed a global immunology and immunotoxicology unit dedicated to the specific needs of biologic drug development.
read more
Wednesday, February 15, 2017
X-Chem, Inc. has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug leads for the treatment of inflammatory disease.
read more
Wednesday, April 06, 2022
Charles River Laboratories International, Inc. has acquired Explora BioLabs Holdings, Inc., a provider of contract vivarium research services.
read more
Societal CDMO, Inc. has been selected by AmyriAD Pharma to provide CDMO services to support the ongoing clinical development of AD101. The compound, a novel T-type calcium channel modulator, is currently in clinical development for the treatment of ...
read more
Tuesday, October 07, 2025
Piramal Pharma Solutions has introduced the PODs (Plan, Own, and Deliver) Project Execution System at its Aurora, Canada facility. The Aurora site implemented this innovative system to execute seamless deliveries to customers amidst a growing ...
read more
COREX Logistics announced the establishment of a representative office in Kazakhstan. Its office based in Almaty will serve the needs of international pharma and biotech conducting clinical research in the country.
read more
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
Monday, November 27, 2017
Brammer Bio announced the completion of renovations and launch of its late-stage clinical capacity and commercial-ready cGMP manufacturing site in Cambridge, Massachusetts for gene therapy products.
read more
Wednesday, December 13, 2017
Science Exchange announced a partnership with Bioinformatics Solutions to offer online access to its protein de novo sequencing services to scientists around the globe.
read more
Thursday, November 01, 2018
Sirona Dx announced the introduction of Imaging Mass Cytometry services on the Fluidigm Hyperion Imaging System to advance biomarker discovery and therapeutic development.
read more
Monday, September 16, 2019
SunGen Pharma has received its seventh ANDA approval from the US Food and Drug Administration.
read more
Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed.
read more
MARLBOROUGH, MASSACHUSETTS, USA — March 12, 2012 — A new white paper detailing how a flexible bioprocessing platform meets the changing needs of biomanufacturing is now available for download from Xcellerex, Inc., at http://www.xcellerex.com/...
read more
Wednesday, December 02, 2015
Affymetrix Inc. and Reveal Biosciences LLC, an advanced tissue technologies company, have announced a partnership agreement through which Reveal will use Affymetrix ViewRNA® ISH products for tissue samples to provide RNA in situ hybridization (ISH) ...
read more
Monday, December 28, 2015
Seattle Genetics, Inc. and Bristol-Myers Squibb have announced that the companies have initiated a phase 1/2 clinical trial of ADCETRIS (brentuximab vedotin) in combination with Opdivo (nivolumab) for patients with CD30-expressing relapsed or ...
read more